Search by Drug Name or NDC

    NDC 00338-9558-10 Eptifibatide 75 mg/100mL Details

    Eptifibatide 75 mg/100mL

    Eptifibatide is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is EPTIFIBATIDE.

    Product Information

    NDC 00338-9558
    Product ID 0338-9558_adec2ba9-b744-4539-98c8-8c9b0be57abe
    Associated GPIs 85153030002010
    GCN Sequence Number 079535
    GCN Sequence Number Description eptifibatide PLAST. BAG 75MG/100ML INTRAVEN
    HIC3 M9P
    HIC3 Description PLATELET AGGREGATION INHIBITORS
    GCN 46043
    HICL Sequence Number 018422
    HICL Sequence Number Description EPTIFIBATIDE
    Brand/Generic Generic
    Proprietary Name Eptifibatide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Eptifibatide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 75
    Active Ingredient Units mg/100mL
    Substance Name EPTIFIBATIDE
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208554
    Listing Certified Through 2024-12-31

    Package

    NDC 00338-9558-10 (00338955810)

    NDC Package Code 0338-9558-10
    Billing NDC 00338955810
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (0338-9558-10) / 100 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2019-02-01
    NDC Exclude Flag N
    Pricing Information N/A